E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/26/2016 in the Prospect News Convertibles Daily.

New Issue: WebMD Health prices $300 million seven-year convertible to yield 2.625%, up 30%

By Rebecca Melvin

New York, May 26 – WebMD Health Corp. priced $300 million of seven-year convertible notes ahead of the market open on Thursday to yield 2.625% and with an initial conversion premium of 30%, according to a release.

Pricing of the Rule 144A deal came at the cheap end of talked terms for a 2.125% to 2.625% coupon and a 30% to 35% premium.

Mizuho Securities USA Inc. was the bookrunner for the deal that came on an overnight basis. There is an over-allotment option for up to an additional $50 million of notes.

The notes are non-callable and will mature June 15, 2023. They have dividend and takeover protection.

Proceeds from the sale will be used for general corporate purposes, which may include acquisitions, repurchases of common shares, repurchases of outstanding convertibles and working capital.

Elmwood Park, N.J.-based WebMD is a provider of health information services.

Issuer:WebMD Health Corp.
Issue:Convertible notes
Amount:$300 million
Greenshoe:$50 million
Maturity:June 15, 2023
Bookrunner:Mizuho Securities USA Inc.
Coupon:2.625%
Price:Par
Yield:2.625%
Conversion premium:30%
Conversion price:$87.07
Conversion ratio: 11.4845 shares
Calls:Non-callable
Puts:No puts
Takeover protection:Yes
Dividend protection:Yes
Price talk:2.125%-2.625%, up 30%-35%
Pricing date:May 26
Settlement date:June 1
Stock symbol:Nasdaq: WBMD
Stock reference price:$66.98 at close May 25
Distribution:Rule 144A
Market capitalization:$2.34 billion

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.